Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 9Lung Neoplasms 5Prostatic Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Neoplasms 2Melanoma 2Glioma 2Colorectal Neoplasms 2Barrett Esophagus 2Adenocarcinoma of Lung 2Thyroid Nodule 1Thyroid Neoplasms 1Spinal Fractures 1Smoking Cessation 1Skin Neoplasms 1Recurrence 1Rectal Neoplasms 1Phyllodes Tumor 1Pancreatic Neoplasms 1Osteoporosis 1Nevus 1Neoplastic Cells, Circulating 1Multiple Pulmonary Nodules 1Lymphoma, Follicular 1Lung Diseases 1Locally Advanced Pancreatic Cancer 1Liver Cirrhosis 1Inflammatory Bowel Diseases 1Hypertension, Portal 1Head and Neck Neoplasms 1

Interventions

Portasystemic Shunt, Transjugular Intrahepatic 2Liver Transplantation 2tremelimumab 1durvalumab 1Radiofrequency Ablation 1Hepatectomy 1Diagnostic Imaging 1Bevacizumab 1Anticoagulants 16-acetylaminocaproic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Hypertension, Portal × Diagnostic Imaging × Clear all
NCT06265272 2025-09-26

Value of [68Ga]Ga-PSMA-11 PET/MRI in the Assessment of Liver Cirrhosis

Massachusetts General Hospital

Recruiting
45 enrolled
Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Hypertension, Portal, Liver Cirrhosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡